Sign inGet started

Lee Tien-Li

Insider CIK 1940120 · AARD Chief Executive Officer, Director, 10% owner · SCLX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AARD Aardvark Therapeutics, Inc A Award deriv2026-02-092026-02-11203,851— $0203,851SEC↗
AARD Aardvark Therapeutics, Inc P Buy2025-12-112025-12-127,000$14.49 $101.4K1,551,613SEC↗
AARD Aardvark Therapeutics, Inc M Exercise deriv2025-10-152025-10-161,229— $040,566SEC↗
AARD Aardvark Therapeutics, Inc M Exercise2025-10-152025-10-161,229$4.24 $5.2K1,544,613SEC↗
AARD Aardvark Therapeutics, Inc P Buy2025-09-152025-09-163,500$9.94 $34.8K1,543,384SEC↗
AARD Aardvark Therapeutics, Inc P Buy2025-09-152025-09-166,500$9.51 $61.8K1,539,884SEC↗
AARD Aardvark Therapeutics, Inc P Buy2025-09-122025-09-125,000$8.50 $42.5K1,533,384SEC↗
AARD Aardvark Therapeutics, Inc P Buy2025-09-112025-09-126,000$7.82 $46.9K1,528,384SEC↗
AARD Aardvark Therapeutics, Inc P Buy2025-09-102025-09-129,000$7.91 $71.2K1,522,384SEC↗
AARD Aardvark Therapeutics, Inc M Exercise deriv2025-08-282025-08-2917,209— $041,795SEC↗
AARD Aardvark Therapeutics, Inc M Exercise2025-08-282025-08-2917,209$4.24 $73.0K1,513,384SEC↗
AARD Aardvark Therapeutics, Inc A Award deriv2025-06-112025-06-13549,534— $0549,534SEC↗
AARD Aardvark Therapeutics, Inc C Conversion deriv2025-02-142025-02-19350,002— $00SEC↗
AARD Aardvark Therapeutics, Inc C Conversion2025-02-142025-02-1941,303— $01,479,633SEC↗
AARD Aardvark Therapeutics, Inc P Buy2025-02-142025-02-1916,542$16.00 $264.7K1,496,175SEC↗
SCLX Scilex Holding Co A Award deriv2023-01-172023-01-17250,000— $0250,000SEC↗